🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kendra K. Radtke

University of California, San Francisco

ORCID: 0000-0002-0578-6554
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Real-World Type 2 Diabetes Second-Line Treatment Allocation Among Patients

medRxiv(2025)10.1101/2025.03.26.25324631
Top 100%
0DataRank
Top 100%0 citations

Rohit Vashisht, Ayan Patel, Suneil K. Koliwad, Atul Janardhan Butte, Kendra K. Radtke +2 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges”.

Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and challenges

Frontiers in Pharmacology(2023)10.3389/fphar.2022.1054688
N/A
0.104DataRank · unranked
1 citations

Atul Janardhan Butte, Kendra K. Radtke

Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children

European Respiratory Journal(2020)10.1183/13993003.01756-2020
N/A
0DataRank · unranked
8 citations

Jennifer Hibma, Anneke C. Hesseling, Rada Savic, Kendra K. Radtke

Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children

Clinical Infectious Diseases(2021)10.1093/cid/ciab641
N/A
0DataRank · unranked
31 citations

Anneke C. Hesseling, Jana Winckler, Heather R. Draper, Belén P. Solans, Stephanie Thee +8 more

Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01705-21
N/A
0DataRank · unranked
6 citations

Jacqueline P. Ernest, Nan Zhang, Nicole C. Ammerman, Eric L. Nuermberger, Robert Belknap +4 more

Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis

Clinical Infectious Diseases(2022)10.1093/cid/ciac252
N/A
0DataRank · unranked
15 citations

Belén P. Solans, Heather R. Draper, H. Simon Schaaf, Jana Winckler, L. van der Laan +7 more

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01448-22
N/A
0DataRank · unranked
10 citations

Kendra K. Radtke, Anneke C. Hesseling, Jana Winckler, H. Simon Schaaf, Heather R. Draper +8 more

Predicted Pharmacokinetic Interactions Between Hormonal Contraception and Single or Intermittently Dosed Rifampicin

The Journal of Clinical Pharmacology(2023)10.1002/jcph.2303
N/A
0DataRank · unranked
1 citations

Jeremy Hill, Anne Schoenmakers, Christiaan Mulder, Emmy van der Grinten, Floor Overbeek +5 more

Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study

UNC Libraries(2023)10.17615/wbnp-s670
N/A
0DataRank · unranked
0 citations

David E. Vance, Kathleen M. Weber, Anandi N. Sheth, M.A. Fischl, Leah H. Rubin +8 more

Real-World Type 2 Diabetes Second-Line Treatment Allocation Among Patients

medRxiv(2025)10.1101/2025.03.26.25324631
Top 100%
0DataRank
Top 100%0 citations

Rohit Vashisht, Ayan Patel, Suneil K. Koliwad, Atul Janardhan Butte, Kendra K. Radtke +2 more

Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3201
N/A
0DataRank · unranked
7 citations

Sarah B. Doernberg, Travis Zack, Atul Janardhan Butte, Kendra K. Radtke, Anu Patel